Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

The human microbiome: opportunity or hype?

Valencia PM, Richard M, Brock J, Boglioli E.

Nat Rev Drug Discov. 2017 Dec;16(12):823-824. doi: 10.1038/nrd.2017.154. Epub 2017 Sep 15. No abstract available.

PMID:
28912600
2.

Calculation of statistic estimates of kinetic parameters from substrate uncompetitive inhibition equation using the median method.

Valencia PL, Astudillo-Castro C, Gajardo D, Flores S.

Data Brief. 2017 Mar 11;11:567-571. doi: 10.1016/j.dib.2017.03.013. eCollection 2017 Apr.

3.

The immuno-oncology race: myths and emerging realities.

Cavnar S, Valencia P, Brock J, Wallenstein J, Panier V.

Nat Rev Drug Discov. 2017 Feb 2;16(2):83-84. doi: 10.1038/nrd.2016.279. No abstract available.

PMID:
28148948
4.

Application of the median method to estimate the kinetic constants of the substrate uncompetitive inhibition equation.

Valencia PL, Astudillo-Castro C, Gajardo D, Flores S.

J Theor Biol. 2017 Apr 7;418:122-128. doi: 10.1016/j.jtbi.2017.01.033. Epub 2017 Jan 24.

PMID:
28130095
5.

[Mansonelosis by mansonella ozzardi in volunteers undergoing screening for malaria in the Peruvian Amazon].

Vargas J, Arróspide N, Gutiérrez S, Obregón C, Valencia P, Mormontoy H.

Rev Peru Med Exp Salud Publica. 2015 Apr-Jun;32(2):265-71. Spanish.

6.

Tissue-engineered autologous vaginal organs in patients: a pilot cohort study.

Raya-Rivera AM, Esquiliano D, Fierro-Pastrana R, López-Bayghen E, Valencia P, Ordorica-Flores R, Soker S, Yoo JJ, Atala A.

Lancet. 2014 Jul 26;384(9940):329-36. doi: 10.1016/S0140-6736(14)60542-0. Epub 2014 Apr 10.

PMID:
24726478
7.

Microfluidic platform for combinatorial synthesis and optimization of targeted nanoparticles for cancer therapy.

Valencia PM, Pridgen EM, Rhee M, Langer R, Farokhzad OC, Karnik R.

ACS Nano. 2013 Dec 23;7(12):10671-80. doi: 10.1021/nn403370e. Epub 2013 Nov 11.

8.

Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study.

Lim JM, Bertrand N, Valencia PM, Rhee M, Langer R, Jon S, Farokhzad OC, Karnik R.

Nanomedicine. 2014 Feb;10(2):401-9. doi: 10.1016/j.nano.2013.08.003. Epub 2013 Aug 20.

9.

Spontaneous formation of heterogeneous patches on polymer-lipid core-shell particle surfaces during self-assembly.

Salvador-Morales C, Valencia PM, Gao W, Karnik R, Farokhzad OC.

Small. 2013 Feb 25;9(4):511-7. doi: 10.1002/smll.201201499. Epub 2012 Oct 26.

10.

[Hantavirus pulmonary syndrome (Rio Mamore virus) in the Peruvian Amazon region].

Casapía M, Mamani E, García MP, Miraval ML, Valencia P, Quino AH, Alvarez C, Donaires LF.

Rev Peru Med Exp Salud Publica. 2012 Jul-Sep;29(3):390-5. Spanish.

11.

Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles.

Valencia PM, Pridgen EM, Perea B, Gadde S, Sweeney C, Kantoff PW, Bander NH, Lippard SJ, Langer R, Karnik R, Farokhzad OC.

Nanomedicine (Lond). 2013 May;8(5):687-98. doi: 10.2217/nnm.12.134. Epub 2012 Oct 17.

12.

Microfluidic technologies for accelerating the clinical translation of nanoparticles.

Valencia PM, Farokhzad OC, Karnik R, Langer R.

Nat Nanotechnol. 2012 Oct;7(10):623-9. doi: 10.1038/nnano.2012.168. Review.

13.

Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.

Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC.

Chem Soc Rev. 2012 Apr 7;41(7):2971-3010. doi: 10.1039/c2cs15344k. Epub 2012 Mar 5. Review.

14.

pep27 and lytA in Vancomycin-Tolerant Pneumococci.

Olivares A, Trejo JO, Arellano-Galindo J, Zuñiga G, Escalona G, Vigueras JC, Marin P, Xicohtencatl J, Valencia P, Velázquez-Guadarram N.

J Microbiol Biotechnol. 2011 Dec;21(12):1345-51.

15.

Recent developments in multifunctional hybrid nanoparticles: opportunities and challenges in cancer therapy.

Salvador-Morales C, Valencia PM, Thakkar AB, Swanson EW, Langer R.

Front Biosci (Elite Ed). 2012 Jan 1;4:529-45. Review.

PMID:
22201893
16.

Batch reactor performance for the enzymatic synthesis of cephalexin: influence of catalyst enzyme loading and particle size.

Valencia P, Flores S, Wilson L, Illanes A.

N Biotechnol. 2012 Jan 15;29(2):218-26. doi: 10.1016/j.nbt.2011.09.002. Epub 2011 Sep 10.

PMID:
21925630
17.

Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles.

Valencia PM, Hanewich-Hollatz MH, Gao W, Karim F, Langer R, Karnik R, Farokhzad OC.

Biomaterials. 2011 Sep;32(26):6226-33. doi: 10.1016/j.biomaterials.2011.04.078. Epub 2011 Jun 11.

18.

[Circulation of a different lineage of dengue virus serotype 2 American / Asian genotype in the Peruvian Amazon, 2010].

Mamani E, Alvarez C, García M M, Figueroa D, Gatti M, Guio H, Merino S, Valencia P, Calampa C, Franco L, Cabezas C.

Rev Peru Med Exp Salud Publica. 2011 Mar;28(1):72-7. Spanish.

19.

Effect of internal diffusional restrictions on the hydrolysis of penicillin G: reactor performance and specific productivity of 6-APA with immobilized penicillin acylase.

Valencia P, Flores S, Wilson L, Illanes A.

Appl Biochem Biotechnol. 2011 Sep;165(2):426-41. doi: 10.1007/s12010-011-9262-7. Epub 2011 Apr 20.

PMID:
21505803
20.

Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels.

Rhee M, Valencia PM, Rodriguez MI, Langer R, Farokhzad OC, Karnik R.

Adv Mater. 2011 Mar 25;23(12):H79-83. doi: 10.1002/adma.201004333. Epub 2011 Feb 22. No abstract available.

Supplemental Content

Loading ...
Support Center